15
Jun
2021
After Devastating New Study, Is There A Future For Workplace Wellness – And Has Peloton Figured It Out?
This is a story about the tension between what we desperately want to believe and what the data suggest we should believe, and — surprise! — this isn’t about the contentious recent approval of the Biogen drug aducanumab for Alzheimer’s Disease. Rather, it’s about a powerful and important study just published in Health Affairs, examining the outcomes of a workplace wellness program in a... Read More
15
Jun
2021
Mentoring Young Scientists: Jay Bradner and Andy Plump on The Long Run
This episode of The Long Run is a little different. I invited a couple previous guests on The Long Run to discuss a specific issue: How the industry can do a better job of mentoring young scientists, and creating on-ramps to careers in the biopharma industry for people from underrepresented groups. Jay Bradner, the president of the Novartis Institutes for... Read More